| Head and Neck Cancer |
1 |
1 |
| Chemotherapy |
0 |
0.99 |
| Biologic Therapy |
0 |
0.7 |
| Cancer |
0 |
0.48 |
| Thrombocytopenia |
0 |
0.48 |
| Antineoplastic Drug |
0 |
0.4 |
| Toxicology |
0 |
0.4 |
| Cervical Region |
0 |
0.36 |
| Genomic Medicine |
0 |
0.34 |
| Healthcare and Medical Technology |
0 |
0.18 |
| Revenue and Practice Management |
0 |
0.16 |
| Patient Safety |
0 |
0.15 |
| Adherence |
0 |
0.12 |
| Adverse Effects |
0 |
0.12 |
| Biomedical Technology |
0 |
0.12 |
| Grant |
0 |
0.12 |
| Immunotherapy |
0 |
0.12 |
| Salary and Compensation |
0 |
0.12 |
| Aminotransferase |
0 |
0.06 |
| Anemia |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Diarrhea |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Neutropenia |
0 |
0.06 |
| Oral Cavity |
0 |
0.06 |
| Platinum |
0 |
0.06 |
| Precision Medicine |
0 |
0.06 |
| Professional Development |
0 |
0.06 |
| Taxane |
0 |
0.06 |
| Tolerance |
0 |
0.06 |
| Tyrosine Kinase Inhibitor |
0 |
0.06 |